Physician profile
Jonathan P Payne
NPI 1073792388
$2,158.72
in general payments reported to CMS, 2019-2025
31 companies · $37.14 in 2025
The $37.14 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $336 · 2021: $682 · 2022: $364 · 2023: $225 · 2024: $129 · 2025: $37.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $454.89 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $194.15 | 2019-2025 | |
| Pfizer INC. | $160.64 | 2019-2024 | |
| Exeltis, USA INC. | $147.53 | 2022-2023 | Slynd |
| Takeda Pharmaceuticals U.S.A., INC. | $132.65 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $122.34 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $110.49 | 2023-2024 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $109.25 | 2020-2021 | |
| Novo Nordisk INC | $107.91 | 2019-2021 | |
| Hologic Sales and Service, LLC | $79.68 | 2019-2023 | Myosure Tissue Removal Device, Novasure, Coolseal Generator |
| Lupin INC. | $71.15 | 2019-2020 | |
| Allergan, INC. | $49.70 | 2019-2020 | |
| Urovant Sciences INC | $37.12 | 2022 | |
| Myovant Sciences INC. | $37.00 | 2022 | |
| Organon LLC | $35.77 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $30.01 | 2024-2025 | Voquezna |
| Scynexis, INC. | $29.74 | 2022 | |
| Avion Pharmaceuticals | $27.62 | 2019 | |
| Duchesnay USA Incorporated | $23.59 | 2019 | |
| Roche Diagnostics Corporation | $23.42 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $22.56 | 2021 | |
| Conmed Corporation | $22.15 | 2023 | Airseal |
| Daiichi Sankyo INC. | $19.09 | 2022 | |
| Therapeuticsmd, INC. | $15.97 | 2022 | |
| Evofem Biosciences, INC. | $15.43 | 2021 | |
| Horizon Therapeutics Plc | $14.86 | 2019 | |
| Shire North American Group INC | $13.91 | 2019 | |
| Amgen INC. | $13.52 | 2022 | |
| Amag Pharmaceuticals, INC. | $12.38 | 2019 | |
| Lilly USA, LLC | $12.16 | 2020 | |
| Agile Therapeutics, INC. | $12.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.